A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005

Administered By

Contributors

Start/End

  • October 16, 2015 - June 30, 2019